# Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)

> **NCT00106938** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 1663 (actual)

## Conditions studied

- Carotid Artery Disease
- Carotid Stenosis
- Stroke
- Atherosclerosis

## Interventions

- **DEVICE:** Carotid artery stenting with filter (interventional)
- **PROCEDURE:** Carotid artery endarterectomy (surgical)

## Key facts

- **NCT ID:** NCT00106938
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 1663 (ACTUAL)
- **Why stopped:** Business decision and not a result of any patient or product safety issues.
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106938, "Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00106938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*